CT of benign hypervascular liver nodules in autoimmune hepatitis.

Department of Radiology, University of California-San Francisco, 505 Parnassus Ave., San Francisco, CA 94143-0628, USA.
American Journal of Roentgenology (Impact Factor: 2.74). 01/2005; 183(6):1573-6. DOI: 10.2214/ajr.183.6.01831573
Source: PubMed

ABSTRACT OBJECTIVE: The purpose of this report is to describe the frequency and histopathologic basis of benign hypervascular liver nodules seen on CT in patients with autoimmune hepatitis. CONCLUSION: Benign hypervascular liver nodules may be seen on CT in patients with cirrhosis due to autoimmune hepatitis and may represent large regenerative nodules. This phenomenon is important to recognize because of the potential for confusion with hepatocellular carcinoma.

  • [Show abstract] [Hide abstract]
    ABSTRACT: To retrospectively describe imaging analyses of benign hypervascular hyperplastic liver nodules (HHN) that resulted from alcoholic liver cirrhosis and to examine the possibility of imaging differentiation between these nodules and hypervascular hepatocellular carcinoma (HCC). Ten histopathologically confirmed HHN arise in alcoholic liver cirrhosis, and 9 HCC were examined. Magnetic resonance imaging (MRI) (10 HHN and 9 HCC), superparamagnetic iron oxide-enhanced T2-weighted MRI (6 HHN and 4 HCC), and dual-phase computed tomography hepatic arteriography (5 HHN and 6 HCC) were performed, respectively. On T1-weighted magnetic resonance images, 7 HHNs showed hyperintensity and 3 showed iso- to hypointensity, and all HCCs showed hypointensity compared with surrounding liver. On T2-weighted magnetic resonance images, 2 HHNs showed hyperintensity and 8 showed iso- to hypointensity. In contrast, 1 HCC showed hypointensity and 8 showed hyperintensity. On superparamagnetic iron oxide-enhanced T2 MRI, all HHNs showed iso- to hypointensity, and all HCCs showed hyperintensity. All HHN and HCCs subjected to dual-phase computed tomography hepatic arteriography showed enhancement on early-phase images and coronalike enhancement on late-phase images. Imaging findings of highly-well differentiated HCCs possibly overlap with HHN. So, for correct diagnosis of HHN, at first, we should suspect HHN based on clinical findings and MRI findings, and then perform core needle biopsy to verify the radiological diagnosis.
    Journal of Computer Assisted Tomography 07/2007; 31(4):557-63. DOI:10.1097/RCT.0b013e3180305bfb · 1.60 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Hepatocellular carcinoma (HCC) is the fastest growing cause of cancer-related death in the United States. Cirrhosis is the most important risk factor for HCC. Dynamic contrast-enhanced magnetic resonance (MR) imaging is the modality of choice for working up nodules detected at screening, for staging known HCC, and for follow-up. In cirrhotic livers, the combination of tumor arterial phase hyperenhancement plus washout and/or capsular enhancement is highly specific for HCC and can make biopsy unnecessary. Newer imaging techniques may further improve MR imaging sensitivity for HCC and help to characterize tumors with atypical dynamic enhancement patterns.
    Magnetic Resonance Imaging Clinics of North America 08/2014; 22(3):315–335. DOI:10.1016/j.mric.2014.04.006 · 0.80 Impact Factor
  • Article: Reply.
    Digestive Diseases and Sciences 06/2013; 58(6):1809-10. · 2.55 Impact Factor